(Q46919851)

26 December 2017

title

Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant (English)

1 reference

26 December 2017

1 reference

1

1 reference

26 December 2017

Garrett Z. Ng

4

1 reference

26 December 2017

Ching-Seng Ang

7

1 reference

26 December 2017

Philip Sutton

10

1 reference

26 December 2017

author name string

Arthi Arulmuruganar

2

1 reference

26 December 2017

Elena Venditti

3

1 reference

26 December 2017

Jia-Xi Han

5

1 reference

26 December 2017

Claire Entwisle

6

1 reference

26 December 2017

Camilo A Colaco

8

1 reference

26 December 2017

Shaun McNulty

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

10 March 2014

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

32

1 reference

26 December 2017

issue

20

1 reference

26 December 2017

page(s)

2350-2358

1 reference

26 December 2017

Helicobacter pylori infection and the development of gastric cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Why can't we make an effective vaccine against Helicobacter pylori?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Immunological aspects of heat-shock proteins-the optimum stress of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Heat shock proteins: conditional mediators of inflammation in tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Surface localized Heat Shock Protein 20 (HslV) of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Considering increased mouse stomach mass when calculating prophylactic vaccine efficacy against Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Helicobacter pylori Heat Shock Protein 60 Mediates Interleukin-6 Production by Macrophages via a Toll-like Receptor (TLR)-2-, TLR-4-, and Myeloid Differentiation Factor 88-independent Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

Low biological activity of Helicobacter pylori lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.051

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2014.02.051

1 reference

26 December 2017

1 reference

26 December 2017